The pathogenesis of MM is closely linked to proteostasis imbalance caused by genetic events and alterations in the BM microenvironment, involving oncogene overexpression (e.g., MYC, MAF) and mutations (e.g., KRAS, NRAS, p53) (Malard et al., 2024). Here, MYC is linked to Miyoshi myopathy.